739 related articles for article (PubMed ID: 32335853)
21. Clinical review: the surgical treatment of idiopathic pseudotumour cerebri (idiopathic intracranial hypertension).
Brazis PW
Cephalalgia; 2008 Dec; 28(12):1361-73. PubMed ID: 19037972
[TBL] [Abstract][Full Text] [Related]
22. Current Indications for Management Options in Pseudotumor Cerebri.
Akhter A; Schulz L; Inger HE; McGregor JM
Neurol Clin; 2022 May; 40(2):391-404. PubMed ID: 35465882
[TBL] [Abstract][Full Text] [Related]
23. Management of idiopathic intracranial hypertension in children utilizing venous sinus stenting.
Schwarz J; Al Balushi A; Sundararajan S; Dinkin M; Oliveira C; Greenfield JP; Patsalides A
Interv Neuroradiol; 2021 Apr; 27(2):257-265. PubMed ID: 33236688
[TBL] [Abstract][Full Text] [Related]
24. Men Are from Mars, Idiopathic Intracranial Hypertension Is from Venous: The Role of Venous Sinus Stenosis and Stenting in Idiopathic Intracranial Hypertension.
Dinkin M; Oliveira C
Semin Neurol; 2019 Dec; 39(6):692-703. PubMed ID: 31847040
[TBL] [Abstract][Full Text] [Related]
25. Optic nerve sheath fenestration for idiopathic intracranial hypertension: a seven year review of visual outcomes in a tertiary centre.
Obi EE; Lakhani BK; Burns J; Sampath R
Clin Neurol Neurosurg; 2015 Oct; 137():94-101. PubMed ID: 26164677
[TBL] [Abstract][Full Text] [Related]
26. Efficacy, complications and cost of surgical interventions for idiopathic intracranial hypertension: a systematic review of the literature.
Kalyvas AV; Hughes M; Koutsarnakis C; Moris D; Liakos F; Sakas DE; Stranjalis G; Fouyas I
Acta Neurochir (Wien); 2017 Jan; 159(1):33-49. PubMed ID: 27830325
[TBL] [Abstract][Full Text] [Related]
27. Endoscopic Endonasal Optic Nerve Decompression in Idiopathic Intracranial Hypertension: When to Implement Optic Nerve Sheath Fenestration.
Ahmedov ML; Tahmazoglu B; Aydin S; Kartum TA; Mergen B; Yildirim SR; Kemerdere R; Tanriover N
Oper Neurosurg (Hagerstown); 2023 Oct; 25(4):315-323. PubMed ID: 37345928
[TBL] [Abstract][Full Text] [Related]
28. Venous sinus stenting for reduction of intracranial pressure in IIH: a prospective pilot study.
Liu KC; Starke RM; Durst CR; Wang TR; Ding D; Crowley RW; Newman SA
J Neurosurg; 2017 Nov; 127(5):1126-1133. PubMed ID: 28009240
[TBL] [Abstract][Full Text] [Related]
29. Idiopathic Intracranial Hypertension - Challenges and Pearls.
Rohit W; Rajesh A; Mridula R; Jabeen SA
Neurol India; 2021; 69(Supplement):S434-S442. PubMed ID: 35103000
[TBL] [Abstract][Full Text] [Related]
30. Efficacy of dural venous sinus stenting in treating idiopathic intracranial hypertension with acute vision loss.
Zehri AH; Lee KE; Kartchner J; Arnel M; Martin T; Wolfe SQ; Fargen KM
Neuroradiol J; 2022 Feb; 35(1):86-93. PubMed ID: 34224285
[TBL] [Abstract][Full Text] [Related]
31. Optic nerve sheath decompression for visual loss in intracranial hypertension: report from a tertiary care center in South India.
Nithyanandam S; Manayath GJ; Battu RR
Indian J Ophthalmol; 2008; 56(2):115-20. PubMed ID: 18292621
[TBL] [Abstract][Full Text] [Related]
32. Venous sinus stenting for idiopathic intracranial hypertension: a systematic review and meta-analysis.
Nicholson P; Brinjikji W; Radovanovic I; Hilditch CA; Tsang ACO; Krings T; Mendes Pereira V; Lenck S
J Neurointerv Surg; 2019 Apr; 11(4):380-385. PubMed ID: 30166333
[TBL] [Abstract][Full Text] [Related]
33. Treatment of idiopathic intracranial hypertension via stereotactic placement of biventriculoperitoneal shunts.
Karsy M; Abou-Al-Shaar H; Bowers CA; Schmidt RH
J Neurosurg; 2018 Feb; 130(1):136-144. PubMed ID: 29393752
[TBL] [Abstract][Full Text] [Related]
34. Mastoiditis caused by intracranial venous sinus stenting in an idiopathic intracranial hypertension patient.
Tian L
Interv Neuroradiol; 2019 Aug; 25(4):478-480. PubMed ID: 31190591
[TBL] [Abstract][Full Text] [Related]
35. Safety and Clinical Outcomes after Transverse Venous Sinus Stenting for Treatment of Refractory Idiopathic Intracranial Hypertension: Single Center Experience.
Kulhari A; He M; Fourcand F; Singh A; Zacharatos H; Mehta S; Kirmani JF
J Vasc Interv Neurol; 2020 Jan; 11(1):6-12. PubMed ID: 32071666
[TBL] [Abstract][Full Text] [Related]
36. Visual outcomes following optic nerve sheath fenestration via the medial transconjunctival approach.
Vaidya NS; Mahmoud AM; Buzzacco D; Katz SE
Orbit; 2016 Oct; 35(5):271-7. PubMed ID: 27541942
[TBL] [Abstract][Full Text] [Related]
37. Retinal Manifestations of Idiopathic Intracranial Hypertension.
Nichani P; Micieli JA
Ophthalmol Retina; 2021 May; 5(5):429-437. PubMed ID: 32860958
[TBL] [Abstract][Full Text] [Related]
38. Long-term efficacy of venous sinus stenting in the treatment of idiopathic intracranial hypertension.
Cheng H; Jin H; Hu Y; Chen L; Chen Z; Zhong G
CNS Neurosci Ther; 2024 Jan; 30(1):e14356. PubMed ID: 37469247
[TBL] [Abstract][Full Text] [Related]
39. Ventriculoperitoneal shunt as a treatment of visual loss in idiopathic intracranial hypertension.
Huang LC; Winter TW; Herro AM; Rosa PR; Schiffman JC; Pasol J; Trombly RS; Tawfik M; Lam BL
J Neuroophthalmol; 2014 Sep; 34(3):223-8. PubMed ID: 24637911
[TBL] [Abstract][Full Text] [Related]
40. Fifty shades of gradients: does the pressure gradient in venous sinus stenting for idiopathic intracranial hypertension matter? A systematic review.
McDougall CM; Ban VS; Beecher J; Pride L; Welch BG
J Neurosurg; 2018 Mar; 130(3):999-1005. PubMed ID: 29498569
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
